Discover latest product news and media coverage about Ultromics.
Cardiologists in Wolverhampton will be the first in the Midlands to use innovative digital technology in a key diagnostic test for heart disease. Red more.
Ultromics announces the launch of EchoGo Core 2.0 – a new resource in the global fight against cardiovascular disease
Northumbria Healthcare NHS Foundation Trust using AI to help detect coronary artery disease
Breakthrough study shows AI is capable of independently reading stress echocardiograms and predicting coronary artery disease, significantly increasing detection compared to traditional methods.
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
Ultromics Announces Collaboration with Janssen to Develop an AI-Powered Diagnostic Device for Patients with Amyloidosis with Cardiac Involvement
Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment
EchoGo Supported Predictors of Cardiac-Related COVID-19 Mortality Revealed in WASE Study
EchoGo Core, the first and only platform to automate ultrasound analysis in the cloud, is now available for use in the UK and Europe
Learn more about how Ultromics' AI platform , EchoGo, is being deployed in the NHS, as part of the NHS AI Virtual Hub 'Show and Tell' sessions
Read more about how clinicians across the NHS can now access EchoGo, through NHS England’s Image Exchange Portal (IEP), to automate ultrasound analysis
Microsoft Azure customers worldwide now gain access to the Ultromics’ EchoGo service for automated echocardiography analysis.
Sign-up to hear about the latest news.
Sign up to newsletter
cases processed
.jpg?noresize)
